Synovus Financial’s Pfizer PFE Stock Holding History

Synovus Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$13M	Sell	512,060 -14,879	-3%	-$367K	0.15%	96
2025 Q2	$12.8M	Sell	526,939 -49,311	-9%	-$1.15M	0.16%	93
2025 Q1	$14.6M	Sell	576,250 -14,861	-3%	-$389K	0.19%	77
2024 Q4	$15.7M	Sell	591,111 -149,616	-20%	-$4.06M	0.2%	71
2024 Q3	$21.4M	Buy	740,727 +78,675	+12%	+$2.3M	0.25%	60
2024 Q2	$18.5M	Sell	662,052 -32,263	-5%	-$888K	0.24%	65
2024 Q1	$19.3M	Sell	694,315 -23,742	-3%	-$659K	0.25%	57
2023 Q4	$20.7M	Buy	718,057 +7,069	+1%	+$214K	0.29%	48
2023 Q3	$23.6M	Buy	710,988 +9,184	+1%	+$325K	0.27%	60
2023 Q2	$25.7M	Buy	701,804 +10,625	+2%	+$414K	0.28%	58
2023 Q1	$28.2M	Sell	691,179 -9,228	-1%	-$399K	0.32%	52
2022 Q4	$35.9M	Buy	700,407 +11,374	+2%	+$545K	0.41%	43
2022 Q3	$30.2M	Buy	689,033 +11,877	+2%	+$577K	0.37%	43
2022 Q2	$35.5M	Buy	677,156 +23,051	+4%	+$1.17M	0.42%	39
2022 Q1	$33.9M	Sell	654,105 -68,958	-10%	-$3.58M	0.36%	37
2021 Q4	$42.7M	Buy	723,063 +11,443	+2%	+$567K	0.42%	33
2021 Q3	$30.6M	Buy	711,620 +19,011	+3%	+$842K	0.32%	44
2021 Q2	$27.1M	Buy	692,609 +4,023	+0.6%	+$156K	0.27%	55
2021 Q1	$24.9M	Sell	688,586 -1,937	-0.3%	-$68.8K	0.28%	54
2020 Q4	$25.4M	Sell	690,523 -25,346	-4%	-$930K	0.29%	45
2020 Q3	$24.9M	Sell	715,869 -513	-0.1%	-$18K	0.33%	44
2020 Q2	$22.2M	Sell	716,382 -156,135	-18%	-$5.3M	0.32%	48
2020 Q1	$27M	Buy	872,517 +160,088	+22%	+$5.45M	0.38%	46
2019 Q4	$26.5M	Buy	712,429 +7,425	+1%	+$264K	0.36%	42
2019 Q3	$24M	Buy	705,004 +11,905	+2%	+$433K	0.36%	46
2019 Q2	$28.5M	Sell	693,099 -1,515	-0.2%	-$60.2K	0.43%	39
2019 Q1	$27.9M	Sell	694,614 -10,890	-2%	-$436K	0.45%	40
2018 Q4	$29.2M	Sell	705,504 -26,144	-4%	-$1.09M	0.53%	35
2018 Q3	$30.6M	Buy	731,648 +7,210	+1%	+$278K	0.48%	35
2018 Q2	$24.9M	Sell	724,438 -3,120	-0.4%	-$107K	0.42%	43
2018 Q1	$24.5M	Buy	727,558 +2,979	+0.4%	+$102K	0.42%	38
2017 Q4	$24.9M	Buy	724,579 +12,751	+2%	+$435K	0.43%	36
2017 Q3	$24.1M	Buy	711,828 +42,418	+6%	+$1.36M	0.46%	35
2017 Q2	$21.3M	Buy	669,410 +16,800	+3%	+$530K	0.43%	38
2017 Q1	$21.2M	Buy	652,610 +7,980	+1%	+$252K	0.44%	37
2016 Q4	$19.8M	Buy	644,630 +19,409	+3%	+$593K	0.45%	39
2016 Q3	$20.1M	Buy	625,221 +46,943	+8%	+$1.57M	0.47%	38
2016 Q2	$19.3M	Buy	578,278 +8,380	+1%	+$267K	0.45%	37
2016 Q1	$16M	Buy	569,898 +16,216	+3%	+$463K	0.39%	43
2015 Q4	$16.9M	Buy	553,682 +17,898	+3%	+$563K	0.42%	43
2015 Q3	$16M	Sell	535,784 -2,146	-0.4%	-$68.8K	0.42%	40
2015 Q2	$17.1M	Sell	537,930 -3,527	-0.7%	-$115K	0.44%	41
2015 Q1	$17.9M	Buy	541,457 +1,413	+0.3%	+$44.9K	0.46%	40
2014 Q4	$16M	Buy	540,044 +342	+0.1%	+$9.81K	0.42%	40
2014 Q3	$15.1M	Buy	539,702 +1,497	+0.3%	+$42K	0.42%	44
2014 Q2	$15.1M	Buy	538,205 +5,738	+1%	+$164K	0.43%	42
2014 Q1	$16.2M	Buy	532,467 +2,737	+0.5%	+$81.6K	0.48%	40
2013 Q4	$15.4M	Sell	529,730 -17,609	-3%	-$512K	0.44%	41
2013 Q3	$14.9M	Sell	547,339 -207,949	-28%	-$5.66M	0.47%	40
2013 Q2	$20.1M	Buy	+755,288	New	+$20.9M	0.61%	30

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Synovus Financial's PFE Position: Q3 2025 in Review

Synovus Financial reduced its Pfizer (PFE) stake by 2.8% in Q3 2025, selling an estimated $367K and leaving 512,060 shares worth $13M. The position accounts for 0.15% of the portfolio, ranked #96.

Synovus Financial first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $42.7M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

Synovus Financial held 512,060 shares of Pfizer worth $13M as of Q3 2025.
Synovus Financial sold 14,879 Pfizer shares in Q3 2025, an estimated $367K.
Pfizer made up 0.15% of Synovus Financial's portfolio in Q3 2025, its #96 holding.
Synovus Financial first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
Synovus Financial's Pfizer position peaked at $42.7M in Q4 2021.
2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.